Wendy Hara

Radiation oncologist

Clinical Assistant Professor, Radiation Oncology - Radiation Therapy

Radiation Oncology

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Head and Neck Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Sarcoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Skin Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: University of Hawaii (2002) HI

Internship: University of Hawaii (2003) HI

Board Certification: Radiation Oncology, American Board of Radiology (2009)

Residency: Stanford - Radiation Oncology (2007) CA

Honors & Awards

Educator of the Year, Association of Residents in Radiation Oncology (2011)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
Trakul, N., Harris, J. P., Le, Q.-T., Hara, W. Y., Maxim, P. G., & Diehn, M. (2012). Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors. JOURNAL OF THORACIC ONCOLOGY, 7(9), 1462-1465.

Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
Kozak, M. M., Murphy, J. D., Schipper, M. L., Donington, J. S., Zhou, L., & Loo, B. W. (2011). Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 6(5), 920-926.